TXA-302

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameTXA-302
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHematopoietic cell growth factors stimulantsProto-oncogene Mas agonists
TargetsHematopoietic cell growth factorsProto-oncogene Mas
Therapy Area/IndicationsMetabolic DiseasesCardiovascular DiseasesStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesConstant Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConstant Therapeutics LLC
Active IndicationsN/A
Inactive IndicationsMetabolic DiseasesCardiovascular DiseasesStroke

Other Information

ATC CodeN/A
Related LinksN/A